Endocrine resistance in breast cancer Treatment of non–small cell lung cancer Phase ii study of temozolomide and thalidomide Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib Temozolomide and thalidomide for treatment of neuroendocrine tumor RUXOLINIB FOR MYELOFIBROSIS Follicular dendritic cell sarcoma Endocrine resistance in breast cancer Colon cancer with brain metastasis Adjuvant chemotherapy in resectable colon cancer with liver metastasis 
